07.02.19
TrakCel appointed Maryellen Papelian as senior director of customer delivery. Maryellen is TrakCel’s latest US senior appointment as the company expands its U.S. management team to support existing business requirements as the number of clients operating in the U.S. continues to grow. Maryellen brings over 20 year’s experience in large-scale IT roll-out implementations focusing on re-engineering business processes.
"TrakCel’s software orchestration platforms are now an integral component throughout much of the international clinical development of the cell and gene therapy industry. As the sector continues to expand, and we work with a greater number of companies, it is critical that we in turn expand capabilities to support existing clients in key international regions. This includes further expansion of our US customer management,” said Ravi Nalliah, CEO, TrakCel. “We selected Maryellen Papelian as a specialist in the implementation of supply chain orchestration platforms at scale. She will provide the integral link between the specific requirements of the client and TrakCel’s software to ensure our individually tailored packages are adjusted on an ongoing basis to the evolving needs of the client.”
“The cell and gene therapy industry continues to grow and evolve. This results in more complex supply chains with broader therapeutic indications and wider geographical clinical operations. These challenges mean the demand for implementation software will continue to increase,” said Maryellen Papelian, senior director of customer delivery, TrakCel. “I have been part of the selection and implementation of a variety of supply chain systems in my recent career. As a result, from that experience, I wanted to apply my technical, commercial and industry experience to TrakCel’s ethos and technical solutions. I feel this is the best option for me to contribute to life changing personalized medicines reaching the market and benefiting patients.”
"TrakCel’s software orchestration platforms are now an integral component throughout much of the international clinical development of the cell and gene therapy industry. As the sector continues to expand, and we work with a greater number of companies, it is critical that we in turn expand capabilities to support existing clients in key international regions. This includes further expansion of our US customer management,” said Ravi Nalliah, CEO, TrakCel. “We selected Maryellen Papelian as a specialist in the implementation of supply chain orchestration platforms at scale. She will provide the integral link between the specific requirements of the client and TrakCel’s software to ensure our individually tailored packages are adjusted on an ongoing basis to the evolving needs of the client.”
“The cell and gene therapy industry continues to grow and evolve. This results in more complex supply chains with broader therapeutic indications and wider geographical clinical operations. These challenges mean the demand for implementation software will continue to increase,” said Maryellen Papelian, senior director of customer delivery, TrakCel. “I have been part of the selection and implementation of a variety of supply chain systems in my recent career. As a result, from that experience, I wanted to apply my technical, commercial and industry experience to TrakCel’s ethos and technical solutions. I feel this is the best option for me to contribute to life changing personalized medicines reaching the market and benefiting patients.”
